NCT05612724View on ClinicalTrials.gov

Rutgers Pilot for PREDICT- Patient POC Test

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

December 30, 2020

Primary Completion Date

January 20, 2021

Study Completion Date

October 31, 2022

Conditions
SARS CoV 2 Infection
Interventions
DEVICE

Testing for SARS CoV2 Antigen

Device: Testing for SARS CoV2 Antigen Antigen testing: Rapid Antigen testing (Point-of-care)

Trial Locations (1)

07103

Rutgers School of Dental Medicine, Newark

All Listed Sponsors
collaborator

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

lead

Rutgers, The State University of New Jersey

OTHER

NCT05612724 - Rutgers Pilot for PREDICT- Patient POC Test | Biotech Hunter | Biotech Hunter